Correlation of EEG biomarkers of cannabis with measured driving impairment

Abstract Objective: The objective of this study was to use electroencephalogram (EEG) biomarkers derived from a short, easily administered neurocognitive testbed to determine acute cannabis intoxication and its effect on driving performance in a driving simulator. Methods: The data analyzed were from a study examining the relationship between psychomotor task performance, EEG data, and driving performance in a simulator. EEG data were collected using a STAT® X-24 EEG Wireless Sensor Headset, which was worn during the psychomotor and driving tasks. Driving data were collected for segments of consistent driving environments, including urban driving, urban curves, interstate, interstate curves, dark rural, and rural straightaways. Dependent measures included measures of lateral and longitudinal vehicle control. Results: There was a significant relationship between impaired driving performance as indicated by increased standard deviation of lane position and EEG power in slow theta band (3–5 Hz) in parietal and occipital areas. Conclusions: These results, combined with our prior reported results, suggest that EEG and electrocardiogram (ECG) acquired concurrent with neuropsychological tests hold potential to provide a highly sensitive, specific, and dose-dependent profile of cannabis intoxication and level of impairment.

[1]  Arnaud Delorme,et al.  EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis , 2004, Journal of Neuroscience Methods.

[2]  Anthony D. McDonald,et al.  Real-Time Detection of Drowsiness Related Lane Departures Using Steering Wheel Angle , 2012 .

[3]  Chris Berka,et al.  Event-related potentials during sustained attention and memory tasks: Utility as biomarkers for mild cognitive impairment , 2018, Alzheimer's & dementia.

[4]  Kenneth Kreutz-Delgado,et al.  ICLabel: An automated electroencephalographic independent component classifier, dataset, and website , 2019, NeuroImage.

[5]  J. Ramaekers,et al.  High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control , 2006, Neuropsychopharmacology.

[6]  Scott Makeig,et al.  The ICLabel dataset of electroencephalographic (EEG) independent component (IC) features , 2019, Data in brief.

[7]  Robin R. Johnson,et al.  Do Drowsy Driver Drugs Differ , 2017 .

[8]  Catalyzing traffic safety advancements via data linkage: Development of the New Jersey Safety and Health Outcomes (NJ-SHO) data warehouse , 2019, Traffic injury prevention.

[9]  C. Deeprose,et al.  Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers , 2010, Journal of psychopharmacology.

[10]  S. Gruber,et al.  Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function , 2016, Front. Pharmacol..

[11]  T. Brown,et al.  Evaluating drugged driving: Effects of exemplar pain and anxiety medications , 2018, Traffic injury prevention.

[12]  S. Gruber,et al.  Age of onset of marijuana use and executive function. , 2012, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.